The U.S. House Democrats' campaign arm said Monday that it's placing a west Michigan candidate into its battlefield program for top 2026 candidates. The "Red to Blue" designation for state Sen. Sean ...
Add Yahoo as a preferred source to see more of our stories on Google. A vessel passes a container ship loaded with shipping containers at the Port of Los Angeles on February 20, 2026. - Mario ...
The next Mega Millions jackpot is an estimated $366 million, with drawings held every Tuesday and Friday. No one won the jackpot in the previous drawing on Friday, Feb. 9. To win a prize, a player ...
MEDINA, Ohio – While significantly more deer were harvested during the city’s 2025 deer management program compared to the previous year, deer-related vehicle incidents in the city were also on the ...
With C.H. Robinson having engineered a turnaround whose fruits are stunningly visible in its stock price–up about 168% in two years, including a post-earnings surge Wednesday evening into Thursday ...
SANTA FE, N.M. (KRQE) – Helping New Mexicans “jumpstart” careers or switch to a new one, the state says its effort to expand adult-focused education-training programs is paying off with hundreds more ...
For the quickest way to join, simply enter your email below and get access. We will send a confirmation and sign you up to our newsletter to keep you updated on all your gaming news.
Carroll Academy will be adding a K-2 program for 2-year-old students beginning in the fall of 2026. Johnny Daves, the head of school at Carroll, says the young students will experience plenty of ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...
Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's ‌new fast-track program after agency scientists flagged safety and ...